ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit

ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit

NEW YORK, Oct. 21, 2024 /PRNewswire/ —  WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Allarity Therapeutics, Inc. (NASDAQ: ALLR) between May 17, 2022 and July 19, 2024, both dates inclusive (the “Class Period”), of the important November 12, 2024 lead plaintiff deadline. So what: If you purchased Allarity … Read more

Rosen Law Firm Encourages Visa Inc. Investors to Inquire About Securities Class Action Investigation

ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit

NEW YORK, Oct. 17, 2024 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Visa Inc. (NYSE: V) resulting from allegations that Visa may have issued materially misleading business information to the investing public. So What: If you purchased Visa securities … Read more

IREN Investors Have Opportunity to Lead Iris Energy Limited Securities Fraud Lawsuit

ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit

NEW YORK, Oct. 12, 2024 /PRNewswire/ —  Why: Rosen Law Firm, a global investor rights law firm, announces that a shareholder has filed a class action lawsuit on behalf of all purchasers of securities of Iris Energy Limited (NASDAQ: IREN) between June 20, 2023 and July 11, 2024. Shareholders who want to serve as a lead … Read more

OFIX Investors Have Opportunity to Lead Orthofix Medical Inc. Securities Fraud Lawsuit

ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit

NEW YORK, Oct. 11, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Orthofix Medical Inc. (NASDAQ: OFIX) between October 11, 2022 and September 12, 2023, both dates inclusive (the “Class Period”), of the important October 21, 2024 lead plaintiff deadline. So what: If you purchased Orthofix … Read more

BMBL Investors Have Opportunity to Lead Bumble Inc. Securities Fraud Lawsuit

ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit

NEW YORK, Oct. 3, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bumble Inc. (NASDAQ: BMBL) between November 7, 2023 and August 7, 2024, both dates inclusive (the “Class Period”), of the important November 25, 2024 lead plaintiff deadline. So what: If you purchased Bumble … Read more

STLA Investors Have Opportunity to Lead Stellantis N.V. Securities Fraud Lawsuit

ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit

NEW YORK, Sept. 28, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Stellantis N.V. (NYSE: STLA) between February 15, 2024 and July 24, 2024, both dates inclusive (the “Class Period”), of the important October 15, 2024 lead plaintiff deadline. So what: If you purchased Stellantis securities … Read more

CRWD Investors Have Opportunity to Lead CrowdStrike Holdings, Inc. Securities Fraud Lawsuit

ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit

NEW YORK, Sept. 8, 2024 /PRNewswire/ —  Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A common stock of CrowdStrike Holdings, Inc. (NASDAQ: CRWD) between November 29, 2023 and July 29, 2024, both dates inclusive (the “Class Period”), of the important September 30, 2024 lead plaintiff deadline. So what: If you … Read more

Rosen Law Firm Encourages Allarity Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation

ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit

NEW YORK, Aug. 19, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Allarity Therapeutics, Inc. (NASDAQ: ALLR) resulting from allegations that Allarity Therapeutics, Inc. may have issued materially misleading business information to the investing public. So what: If … Read more

CXM Investors Have Opportunity to Lead Sprinklr, Inc. Securities Fraud Lawsuit

ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit

NEW YORK, Aug. 16, 2024 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of securities of Sprinklr, Inc. (NASDAQ: CXM) between March 29, 2023 and June 5, 2024. Shareholders who want to serve as lead plaintiff for the class must … Read more

Rosen Law Firm Encourages Paragon 28, Inc. Investors to Inquire About Securities Class Action Investigation

ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit

NEW YORK, Aug. 11, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Paragon 28, Inc. (NYSE: FNA) resulting from allegations that Paragon 28 may have issued materially misleading business information to the investing public. So what: If you purchased Paragon … Read more